Venus Medtech Hangzhou has been granted a patent for a prosthetic heart valve with an annular spacer and central valve section. The design allows for secure anchoring and controlled deployment within the heart, improving the effectiveness of the valve replacement procedure. GlobalData’s report on Venus Medtech Hangzhou gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on Venus Medtech Hangzhou, Prosthetic cardiac valves was a key innovation area identified from patents. Venus Medtech Hangzhou's grant share as of April 2024 was 48%. Grant share is based on the ratio of number of grants to total number of patents.
Prosthetic heart valve with anchoring protrusion for secure implantation
A recently granted patent (Publication Number: US11969163B2) discloses a prosthetic heart valve comprising an annular spacer and a central valve section. The annular spacer includes a cylindrical skirt with a spacer opening and a disc-shaped wall, while the central valve section has a hollow body to support a valve prosthesis and anchoring protrusions to prevent axial movement relative to the spacer. The design allows the central valve section to expand radially within the heart and move into the spacer opening, ensuring secure placement within the native heart valve. Additionally, the cylindrical skirt can be inverted post-deployment to optimize positioning within the heart.
Furthermore, the patent details various configurations and features of the prosthetic heart valve, such as the positioning of the disc-shaped wall, anchoring protrusions, and extension into the heart's ventricle. The central valve section is designed with a flexible wire frame and strut junctions to enhance stability and prevent migration within the annular spacer. The innovative design also includes a support stent with a covering to obstruct blood flow, ensuring efficient valve function. With a focus on secure deployment and optimal positioning within the heart, this prosthetic heart valve design offers promising advancements in the field of cardiac care and treatment of heart valve conditions.
To know more about GlobalData’s detailed insights on Venus Medtech Hangzhou, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.